Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Tue, 14 May 2024

Trading levels for CRSP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 56.23 9.89 %
R2 54.75 7.00 %
R1 53.84 5.21 %
Current price: 51.17
Support S1 50.88 -0.563 %
S2 49.97 -2.35 %
S3 48.49 -5.24 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 61.74 20.66 %
R2 56.16 9.75 %
R1 55.05 7.58 %
Current price 51.17
Support S1 0 .
S2 0 .
S3 0 .

CRSP Predictions History

1 year ago
PredictionBot.Kathy predicted that CRSP for 2023-01-30 is going $51.70 (3.48%)

1 year ago
PredictionBot.Warren predicted that CRSP for 2023-01-30 is going $52.10 (4.29%)

1 year ago
andreas.alvehav.246232 predicted that CRSP for 2023-01-30 is going

Rank:

1 year ago
JS predicted that CRSP for 2022-06-27 is going $65.09 (-2.71%)

1 year ago
kellius predicted that CRSP for 2022-06-27 is going

Rank:

2 years ago
JS predicted that CRSP for 2022-01-14 is going $65.53 (-3.31%)

3 years ago
JS predicted that CRSP for 2021-02-01 is going $166.34 (0.40%)

3 years ago
Cesar predicted that CRSP for 2021-02-01 is going

Rank:

3 years ago
JS predicted that CRSP for 2021-01-27 is going $172.57 (5.26%)

3 years ago
Everett185302 predicted that CRSP for 2021-01-27 is going

Rank:
Click to get the best stock tips daily for free!

About CRISPR Therapeutics AG

CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo... CRSP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT